Tue, May 22, 2012
Mon, May 21, 2012
Sun, May 20, 2012
Sat, May 19, 2012
Fri, May 18, 2012
Thu, May 17, 2012
Wed, May 16, 2012
Tue, May 15, 2012
Mon, May 14, 2012
Sun, May 13, 2012
Sat, May 12, 2012
Fri, May 11, 2012
Thu, May 10, 2012
Wed, May 9, 2012
Tue, May 8, 2012

Aethlon Medical to Present at Today's Security Research Associates 8th Annual Growth Conference


//health-fitness.news-articles.net/content/2012/ .. rch-associates-8th-annual-growth-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


Aethlon Medical to Present at Today's Security Research Associates 8th Annual Growth... -- SAN DIEGO, May 15, 2012 /PRNewswire/ --

Aethlon Medical to Present at Today's Security Research Associates 8th Annual Growth Conference

SAN DIEGO, May 15, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), announced that Chairman and CEO James A. Joyce will present at today's Security Research Associates (SRA) 8th Annual Growth Stock Conference.  The Conference will be held at the Le Meriden Hotel in San Francisco.  A live webcast of the presentation will begin at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) and can be accessed online at: [ http://wsw.com/webcast/sra13/aemd/ ]

(Photo: [ http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b ])

The webcast and archived replay of the company's presentation may be accessed in the Investor Relations section of the Company's website at [ www.aethlonmedical.com ].

About Aethlon Medical

The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with DARPA that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit [ www.aethlonmedical.com ].

Contacts:

James A. Joyce
Chairman and CEO
858.459.7800 x301
[ jj@aethlonmedical.com ]

Jim Frakes
Chief Financial Officer
858.459.7800 x300
[ jfrakes@aethlonmedical.com ]

Marc Robins
877.276.2467
[ mr@aethlonmedical.com ]

SOURCE Aethlon Medical, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.aethlonmedical.com ]


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear